Postpartum uterine involution dysfunction
Conditions
Interventions
Experimental group:Acupuncture
Control Group:Routine care
Sponsors
Beijing Tongzhou District Maternal and Child Health Hospital
Eligibility
Sex/Gender
Female
Age
25 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1) Women aged 25-35 years, scheduled for cesarean delivery; 2) Singleton, full-term pregnancy, without underlying diseases or pregnancy complications; 3) All underwent a transverse lower segment uterine incision, with intraoperative blood loss <400 mL; 4) Neonatal Apgar score of 8-10; 5) Meet the diagnostic criteria for qi deficiency and blood stasis syndrome as outlined in "Gynecology in Traditional Chinese Medicine" and the "Guidelines for Clinical Research of NewDrugs (Trial Version)"; 6) Women without cognitive impairments, with good compliance, who agree to receive treatment in either the experimental or control group and have signed the informed consent form, with postpartum conditions allowing telephone follow-up and the ability to return to the hospital for follow-up at 42 days post-operation. Only those who fully meet the above criteria may be enrolled as subjects
Exclusion criteria
Exclusion criteria: 1) Preterm or post-term pregnancy; 2) Multiple pregnancies; 3) Cesarean section due to placental abruption, fetal distress, etc.; 4) Preoperative treatment with uterine contraction inhibitors or oxytocin induction; 5) Genital tumors (e.g., uterine fibroids, ovarian tumors, vulvar tumors, etc., both benign and malignant); 6) Acute or chronic genital tract inflammation (e.g., vaginitis, pelvic inflammatory disease, etc.); 7) History of cesarean section with uterine scar or previous infection after intrauterine surgery; 8) Complications during delivery (e.g., eclampsia, premature rupture of membranes, placenta previa, placental abruption, placenta accreta, placental adherence, retained placenta, postpartum hemorrhage, disseminated intravascular coagulation, etc.); 9) Severe pregnancy-related complications, including: - Hematological diseases (e.g., idiopathic thrombocytopenic purpura, moderate to severe anemia, aplastic anemia, and various types of leukemia, etc.); - Other internal and surgical conditions that may affect maternal coagulation function and postpartum uterine contractions (e.g., vascular, hepatic, renal, and other major organ diseases, diabetes, infectious diseases, etc.); 10) Neonate with low birth weight or macrosomia; 11) Mental disorders or impaired consciousness; 12) Exclusion criteria: failure to follow treatment and follow-up protocols, making it impossible to assess efficacy and safety. If any of the above conditions are met, exclusion is required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pelvic ultrasound at 42 days postpartum.; | — |
Countries
China
Contacts
Public ContactLi Yi
Beijing Tongzhou District Maternal and Child Health Hospital
Outcome results
None listed